Cancer Treatment Eliminates 90% of Cells in 30 Minutes
“`html
LEAD Light Therapy Shows Promise in Targeting Cancer Cells with Minimal side Effects
Table of Contents
A new photothermal therapy utilizing LED lights and tin oxide (snox) chips demonstrates significant cancer cell kill rates *in vitro* while largely sparing healthy cells, offering a potentially safer and more accessible alternative to traditional cancer treatments.
How the Treatment Works
The research, led by Dr. Jane Ann Incorvia, focuses on leveraging the properties of tin oxide (SnOx) chips. These chips, when exposed to LED light, generate heat. This heat selectively targets and destroys cancer cells. High temperatures disrupt protein function and cell membranes, ultimately leading to cell death. Importantly, the treatment can also trigger an immune response, potentially amplifying the anti-cancer effect by prompting the body to attack remaining cancer cells.
In laboratory tests, the treatment eliminated up to 90% of melanoma cells and 50% of colon cancer cells after 30 minutes of LED light exposure. crucially, healthy cells remained largely unaffected, a significant advantage over conventional therapies.
Advantages Over Traditional Cancer Treatments
Traditional cancer treatments like chemotherapy and radiation therapy are frequently enough associated with debilitating side effects, including hair loss, nausea, and a weakened immune system. This new LED-based photothermal therapy aims to minimize these adverse effects. The use of LEDs, rather than more expensive and specialized lasers, is a key factor in its potential for wider accessibility.
Dr. Incorvia, a nanodevice researcher and study leader, explained, “We were looking to create a treatment that was not only effective, but safe and accessible.” She added that combining LED light with SnOx chips allows for precise targeting of cancer cells while preserving healthy tissue.
The future of Photothermal Therapy
Photothermal therapy has traditionally relied on expensive lasers, limiting its availability to specialized facilities. This new method, utilizing readily available and cost-effective LEDs, opens the door to broader submission and potentially even home-based treatment, particularly for skin cancer patients following surgical procedures. The lower cost of LEDs compared to lasers coudl substantially reduce treatment expenses, making it more accessible to a wider patient population.
This research represents a significant step forward in the field of cancer treatment, offering a promising avenue for developing safer, more effective, and more accessible therapies. Further research and clinical trials are needed to validate these findings and determine the optimal protocols for human application.